Efficacy and safety of nab-paclitaxel chemotherapy for patients with gastric carcinoma: A systematic review and single arm meta-analysis
-
Published:2024-01
Issue:1
Volume:2
Page:25-37
-
ISSN:2949-7523
-
Container-title:Gastroenterology & Endoscopy
-
language:en
-
Short-container-title:Gastroenterology & Endoscopy
Author:
Madeeh Alyaa Khaled,
Farouk Hossam Khaled,
Belal Mohamed Mohamed,
Ramadan Sara,
Al-Masri Batool Emad,
Samier Mohamed,
Gadallah Salama Ahmed,
Khapoli Naseba,
Nashwan Abdulqadir J.ORCID,
AbdelQadir Yossef Hassan
Reference11 articles.
1. Latest Global Cancer Data – IARC [Internet],2018
2. Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial;Mavroudis;Am J Clin Oncol,2000
3. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel;Desai;Clin Cancer Res,2006
4. Key statistical assumptions and methods in one-arm meta-analyses with binary endpoints and low event rates, including a real-life example in the area of endoscopic colonic stenting. Schumacher U, editor;Rousseau;Cogent Med,2017
5. Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases;Ceelen;EBioMedicine,2022